Poland· PL-100004822

Aminomel Nephro

A lösungen zur parenteralen ernährung, kombinationen product containing preparat złożony, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAminomel NephroATCB05BA10REGISTER NO.PL-100004822PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Preparat złożony
Manufacturer
Baxter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990261727
  • gtin
    05909990261710

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7c1624f2-5b32-4ae1-aae9-c5c8b6b77cf8
GET /v1/drugs/7c1624f2-5b32-4ae1-aae9-c5c8b6b77cf8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do infuzji",
  "source": "urpl",
  "strength": "-",
  "packaging": "Lz ¦ Skasowane ¦ 739\n10 fl. 250 ml\nLz ¦ Skasowane ¦ 740\n10 fl. 500 ml\n05909990261727 ¦ Lz ¦ 13396\n1 butelka 500 ml\n05909990261710 ¦ Lz ¦ 48587\n1 butelka 250 ml",
  "substance": "L-izoleucyna 6 g/1000 ml + L-Leucinum 6.4 g/1000 ml + L-Lysini acetas 10.27 g/1000 ml + L-metionina 4.59 g/1000 ml + L-fenyloalanina 5.53 g/1000 ml + L-treonina 5.13 g/1000 ml + L-Tryptophanum 2.05 g/1000 ml + L-walina 5.13 g/1000 ml + L-Argininum 30.2 g/1000 ml + L-Histydyna 3.88 g/1000 ml + L-Alanine 2.59 g/1000 ml + Acidum glutamicum 2.16 g/1000 ml + Glicyna 1.29 g/1000 ml + L-Prolinum 1.66 g/1000 ml + L-Serinum 2.59 g/1000 ml + Acetylcysteinum 0.54 g/1000 ml + N-acetylo-L-tyrozyna 0.37 g/1000 ml",
  "common_name": "Preparat złożony",
  "pl_product_id": "100004822",
  "pozwolenie_nr": "02617",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.